Zanamivir Rotacap
Zanamivir Rotacap Specification
- CAS No
- 139110-80-8
- Grade
- Pharmaceutical Grade
- Application
- Clinic, Hospital, Personal
- Molecular Formula
- C12H20N4O7
- Purity
- 99%
- Formulations Type
- General Drugs
- Formulations Form
- Capsules
- Treatments & Functions
- Antiviral, used for Influenza
- Gender/Age Group
- Adult
- Dosage Guidelines
- As prescribed by physician
- Volume
- 10 Rotacaps per box
- Storage Instructions
- Dry Place
- Pack Type
- Blister Pack
- Route of Administration
- Inhalation
- Prescription/Non Prescription
- Prescription
- Brand Name
- Zanamivir Rotacap
- Shelf Life
- 24 Months
- Active Ingredient
- Zanamivir
Zanamivir Rotacap Trade Information
- Minimum Order Quantity
- 500 Boxes
- FOB Port
- Mundra Port
- Supply Ability
- 10000 Boxes Box Per Month
- Delivery Time
- 30 Days
- Sample Available
- Yes
- Sample Policy
- Sample costs shipping and taxes has to be paid by the buyer
- Packaging Details
- As Per Buyer Requirements
- Main Export Market(s)
- Australia, North America, Eastern Europe, Middle East, Africa, Western Europe, Central America, South America, Asia
- Main Domestic Market
- All India
- Certifications
- ISO, GMP, WHO, FDA

More Products in Critical Care Products Category
Tenofovir Disoproxil fumarate Tablet
Price 10-15 USD ($)
Minimum Order Quantity : 500 Boxes
Gender/Age Group : Adult
Storage Instructions : Dry Place
Formulations Type : General Drugs
Formulations Form : Tablets
Valganciclovir Tablet
Price 10-15 USD ($)
Minimum Order Quantity : 500 Boxes
Gender/Age Group : Other, Suitable for Adults
Storage Instructions : Dry Place
Formulations Type : General Drugs
Formulations Form : Tablets
Filgrastim Injection
Price 5-10 USD ($)
Minimum Order Quantity : 500 Boxes
Gender/Age Group : Other, Adult, Children
Storage Instructions : Store in Cool
Formulations Type : Injectables
Formulations Form : Liquid
Lamivudine and stavudine Tablets
Gender/Age Group : Adult
Storage Instructions : Dry Place
Formulations Type : General Drugs
Formulations Form : Tablets

Send Inquiry




